Transfection efficiency influenced by aggregation of DNA/polyethylenimine max/magnetic nanoparticle complexes

Gene delivery using magnetic nanoparticles (MNPs) is known as magnetofection and is an efficient non-viral gene delivery system. γ-Fe2O3 nanoparticles (primary diameter = 29 nm) and Fe3O4 nanoparticles (primary diameter = 20–30 nm) coated with deacylated linear polyethylenimine (PEI max) were prepared and conjugated with DNA. The dependency of transfection efficiency on the weight of MNPs, viability of HeLa cells, and size of DNA/PEI max/MNP complexes was evaluated. Transfection efficiency initially increased with the weight of the complexes; however, it decreased with further increase in weight. In contrast, cell viability increased with further increase in weight. Cytotoxicity assay showed that the decline in transfection efficiency at higher weights was not attributable to cytotoxicity of DNA/PEI max/MNP complexes. The DNA/PEI max/MNP complexes aggregated because of DNA binding and pH interaction with the medium. Aggregation depending on the weight of MNPs was confirmed. The number of complexes was estimated from the size distribution. In addition, the dependency of the transfection efficiency on aggregation was assessed with respect to cellular endocytic pathways using the complexes. The complexes were internalized through clathrin-dependent endocytosis, which was a size-dependent pathway. This study reveals that decreased transfection efficiency was associated with the extent of aggregation, which was induced by high weight of MNPs.

[1]  Stefaan C. De Smedt,et al.  Cationic Polymer Based Gene Delivery Systems , 2000, Pharmaceutical Research.

[2]  R. Langer,et al.  Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis , 2005, The journal of gene medicine.

[3]  C. Ozkan,et al.  Dendrimer-modified magnetic nanoparticles enhance efficiency of gene delivery system. , 2007, Cancer research.

[4]  M. Hasegawa,et al.  A novel non-viral gene transfer system, polycation liposomes. , 2001, Advanced drug delivery reviews.

[5]  Q. Pankhurst,et al.  Applications of magnetic nanoparticles in biomedicine , 2003 .

[6]  Tymish Y. Ohulchanskyy,et al.  Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[7]  R. Amal,et al.  Polyethylenimine based magnetic iron-oxide vector: the effect of vector component assembly on cellular entry mechanism, intracellular localization, and cellular viability. , 2010, Biomacromolecules.

[8]  M Ferrari,et al.  The role of specific and non-specific interactions in receptor-mediated endocytosis of nanoparticles. , 2007, Biomaterials.

[9]  Masatoshi Watanabe,et al.  Application of Magnetic Nanoparticles to Gene Delivery , 2011, International journal of molecular sciences.

[10]  E. Wagner,et al.  Design and gene delivery activity of modified polyethylenimines. , 2001, Advanced drug delivery reviews.

[11]  Qing Ge,et al.  Full deacylation of polyethylenimine dramatically boosts its gene delivery efficiency and specificity to mouse lung. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Rosenecker,et al.  Insights into the mechanism of magnetofection using PEI‐based magnetofectins for gene transfer , 2004, The journal of gene medicine.

[13]  Haeshin Lee,et al.  DNA transfection using linear poly(ethylenimine) prepared by controlled acid hydrolysis of poly(2-ethyl-2-oxazoline). , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[14]  J. Rosenecker,et al.  The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery , 2003, Biological chemistry.

[15]  M. Toyoda,et al.  Efficient transfection method using deacylated polyethylenimine-coated magnetic nanoparticles , 2011, Journal of Artificial Organs.

[16]  Bai Yang,et al.  Antitumor effect of human TRAIL on adenoid cystic carcinoma using magnetic nanoparticle-mediated gene expression. , 2013, Nanomedicine : nanotechnology, biology, and medicine.

[17]  Тетяна Миколаївна Плохута,et al.  Application of magnetic nanoparticles in biomedicine , 2011 .

[18]  C. Röcker,et al.  Modeling receptor-mediated endocytosis of polymer-functionalized iron oxide nanoparticles by human macrophages. , 2011, Biomaterials.

[19]  H. Hofmann,et al.  Characterization of PEI-coated superparamagnetic iron oxide nanoparticles for transfection: Size distribution, colloidal properties and DNA interaction , 2007 .

[20]  Si-Shen Feng,et al.  Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. , 2005, Biomaterials.

[21]  O. Danos,et al.  Polyethylenimine‐mediated gene delivery: a mechanistic study , 2001, The journal of gene medicine.

[22]  J. Engbersen,et al.  Flotillin-dependent endocytosis and a phagocytosis-like mechanism for cellular internalization of disulfide-based poly(amido amine)/DNA polyplexes. , 2011, Biomaterials.

[23]  Doris A Taylor,et al.  Improved Efficacy of Stem Cell Labeling for Magnetic Resonance Imaging Studies by the Use of Cationic Liposomes , 2003, Cell transplantation.

[24]  Vincent M Rotello,et al.  Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. , 2008, ACS nano.

[25]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[26]  Forrest M Kievit,et al.  PEI–PEG–Chitosan‐Copolymer‐Coated Iron Oxide Nanoparticles for Safe Gene Delivery: Synthesis, Complexation, and Transfection , 2009, Advanced functional materials.

[27]  Hirokazu Akiyama,et al.  Genetically engineered angiogenic cell sheets using magnetic force-based gene delivery and tissue fabrication techniques. , 2010, Biomaterials.

[28]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[29]  L. Gutiérrez,et al.  Insight into serum protein interactions with functionalized magnetic nanoparticles in biological media. , 2012, Langmuir : the ACS journal of surfaces and colloids.

[30]  R. Weissleder,et al.  Linear polyethyleneimine grafted to a hyperbranched poly(ethylene glycol)-like core: a copolymer for gene delivery. , 2006, Bioconjugate chemistry.

[31]  J. Behr,et al.  Systemic linear polyethylenimine (L‐PEI)‐mediated gene delivery in the mouse , 2000, The journal of gene medicine.

[32]  C. Cho,et al.  Biostability of γ-Fe2O3 nano particles Evaluated using an in vitro cytotoxicity assays on various tumor cell lines , 2011 .

[33]  M. Conese,et al.  Role of clathrin- and caveolae-mediated endocytosis in gene transfer mediated by lipo- and polyplexes. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  E. Furlani,et al.  Field, force and transport analysis for magnetic particle-based gene delivery , 2012 .

[35]  A. Mikos,et al.  Poly(ethylenimine) and its role in gene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Chen Chen,et al.  Internalization and Trafficking of Cell Surface Proteoglycans and Proteoglycan‐Binding Ligands , 2007, Traffic.

[37]  A. Rich,et al.  Actin associated with membranes from 3T3 mouse fibroblast and HeLa cells , 1975, The Journal of cell biology.

[38]  Arthur Chiou,et al.  Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images , 2010, Journal of nanobiotechnology.

[39]  J. George,et al.  Idiopathic thrombocytopenic purpura: A concise summary of the pathophysiology and diagnosis in children and adults. , 1998, Seminars in hematology.

[40]  M. Kržan,et al.  Surface modified magnetic nanoparticles for immuno-gene therapy of murine mammary adenocarcinoma. , 2012, Biomaterials.

[41]  Xiang Gao,et al.  Nonviral gene delivery: What we know and what is next , 2007, The AAPS Journal.

[42]  V. Labhasetwar,et al.  Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. , 2002, International journal of pharmaceutics.

[43]  H. Gu,et al.  Control of aggregate size of polyethyleneimine-coated magnetic nanoparticles for magnetofection , 2009 .

[44]  S. Seino,et al.  Dispersibility improvement of gold/iron-oxide composite nanoparticles by polyethylenimine modification , 2009 .

[45]  R. Amal,et al.  Assembly of polyethylenimine-based magnetic iron oxide vectors: insights into gene delivery. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[46]  K. Mislick,et al.  Evidence for the role of proteoglycans in cation-mediated gene transfer. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Behr,et al.  In vitro gene delivery to hepatocytes with galactosylated polyethylenimine. , 1997, Bioconjugate chemistry.

[48]  H. Johnson,et al.  Stability of Anhysteretic Remanent Magnetization in Fine and Coarse Magnetite and Maghemite Particles , 1975 .

[49]  Yong Ai,et al.  Molecular Modeling Studies of 4,5-Dihydro-1H-pyrazolo[4,3-h] quinazoline Derivatives as Potent CDK2/Cyclin A Inhibitors Using 3D-QSAR and Docking , 2010, International journal of molecular sciences.

[50]  J Henke,et al.  Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo , 2002, Gene Therapy.

[51]  J. McCord.  Iron, free radicals, and oxidative injury. , 2004, Seminars in hematology.

[52]  Gaurav Sahay,et al.  Endocytosis of nanomedicines. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[53]  Huajian Gao,et al.  Mechanics of receptor-mediated endocytosis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.